A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

NCT02547220 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
39
Enrollment
INDUSTRY
Sponsor class

Stopped Following a pre-scheduled interim analysis performed by the DMC, it was determined that the study met the pre-specified criteria for futility.

Conditions

Interventions

Sponsor

Shire